Spyre Therapeutics, Inc.
SYRE News Today: Stay Updated with the Latest Spyre Therapeutics, Inc. News in Real Time
Find SYRE news now at Meyka AI. Stay informed with the latest Spyre Therapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
A5A.F American Aires (XETRA) down 60.00% pre-market 27 Mar 2026: Key levels
A5A.F stock drops 60.00% pre-market on 27 Mar 2026; quick snapshot, Meyka grade and €0.01284 forecast
META Stock Today: March 27 — Dividend Lands, 2027 EPS Hiked on AI
Meta share price watch: Dividend of $0.525 paid Mar 26 as Erste lifts FY2027 EPS on AI. What this means for Singapore investors ahead of Apr 29 results, valuation, and risks.
ROK stock $354.82 close Mar 26, 2026 NYSE Rockwell Automation, Inc.: AI demand underpins outlook
ROK stock closed at $354.82 on Mar 26, 2026; our ROK stock analysis covers earnings, valuation, Meyka AI forecast and risks
Kokopelli (4167.T) +45.32% intraday on JPX 27 Mar 2026: volume spike may extend move
Intraday: 4167.T stock jumps 45.32% to JPY 404.00 on JPX 27 Mar 2026 with heavy volume and model forecast
CXBS stock jumps 19900.00% to USD 0.0002 on PNK: model signals 4,900.00% upside
CXBS stock jumps to USD 0.0002 on PNK; Meyka AI forecast shows **4,900.00%** upside and a B (HOLD) grade
TMD.TO Titan Medical (TSX) up 2,150% to C$1.13 on 26 Mar 2026: monitor catalysts
High-volume move: TMD.TO stock hit C$1.13 on 26 Mar 2026 with volume 117,220. Short-term analysis and Meyka AI forecast
ISYX rises 558083792.62%: In-Systcom Inc. (ISYX PNK) 26 Mar 2026 liquidity alert
ISYX stock jumps on heavy volume to $0.000001; we review drivers, risks, and a Meyka AI forecast for investors
6740.T stock +30.65% pre-market 27 Mar 2026: Japan Display (JPX) volume surge
Pre-market update on 6740.T stock: Japan Display jumps to JPY 81.00 on heavy volume in JPX trading
BLK Stock Today, March 26: Asset-Manager Weakness Flags AUM Risk
BlackRock stock slips as AUM growth slows. We explain today’s move, iShares ETF flows, valuation, and what German investors should watch into April earnings.